SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe European heart journal 44 (28), 2544-2556, 2023 | 135 | 2023 |
Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation S Kaptoge, SRK Seshasai, L Sun, M Walker, T Bolton, S Spackman, ... The Lancet Diabetes & Endocrinology 11 (10), 731-742, 2023 | 99 | 2023 |
Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis LJ Appel, M Grams, M Woodward, K Harris, H Arima, J Chalmers, ... Jama 330 (13), 1266-1277, 2023 | 95 | 2023 |
Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review H Cioltan, S Alshehri, C Howe, J Lee, M Fain, H Eng, K Schachter, ... BMC geriatrics 17, 1-12, 2017 | 95 | 2017 |
Length of hospital stay and dementia: a systematic review of observational studies T Möllers, H Stocker, W Wei, L Perna, H Brenner International Journal of Geriatric Psychiatry 34 (1), 8-21, 2019 | 88 | 2019 |
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores H Stocker, T Möllers, L Perna, H Brenner Translational psychiatry 8 (1), 166, 2018 | 87 | 2018 |
Association of plasma biomarkers, p‐tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long‐term clinical Alzheimer's disease risk: results … H Stocker, L Beyer, L Perna, D Rujescu, B Holleczek, K Beyreuther, ... Alzheimer's & Dementia 19 (1), 25-35, 2023 | 61 | 2023 |
Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based … H Stocker, L Perna, K Weigl, T Möllers, B Schöttker, H Thomsen, ... Molecular psychiatry 26 (10), 5812-5822, 2021 | 57 | 2021 |
Association of kidney function with development of Alzheimer disease and other dementias and dementia-related blood biomarkers H Stocker, L Beyer, K Trares, L Perna, D Rujescu, B Holleczek, ... JAMA network open 6 (1), e2252387-e2252387, 2023 | 54 | 2023 |
Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years L Beyer, H Stocker, D Rujescu, B Holleczek, J Stockmann, A Nabers, ... Alzheimer's & Dementia 19 (3), 1020-1028, 2023 | 52 | 2023 |
Meta-analyses identify DNA methylation associated with kidney function and damage P Schlosser, A Tin, PR Matias-Garcia, CHL Thio, R Joehanes, H Liu, ... Nature communications 12 (1), 7174, 2021 | 49 | 2021 |
Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors H Stocker, A Nabers, L Perna, T Möllers, D Rujescu, A Hartmann, ... Alzheimer's & Dementia, 2019 | 47 | 2019 |
Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies M Gorski, H Rasheed, A Teumer, LF Thomas, SE Graham, ... Kidney international 102 (3), 624-639, 2022 | 35 | 2022 |
Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study K Trares, M Bhardwaj, L Perna, H Stocker, A Petrera, SM Hauck, ... Alzheimer's Research & Therapy 14 (1), 128, 2022 | 32 | 2022 |
Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease … TNM Nguyen, LJ Chen, K Trares, H Stocker, B Holleczek, K Beyreuther, ... Alzheimer's Research & Therapy 14 (1), 75, 2022 | 26 | 2022 |
Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over … H Stocker, K Trares, L Beyer, L Perna, D Rujescu, B Holleczek, ... Alzheimer's Research & Therapy 15 (1), 129, 2023 | 21 | 2023 |
Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort-a comparison to the EWGSOP2 cut-off points MT Huemer, A Kluttig, B Fischer, W Ahrens, S Castell, N Ebert, S Gastell, ... Age and Ageing 52 (1), afac324, 2023 | 21 | 2023 |
Association between a polymorphic variant in the CDKN2B‐AS1/ANRIL gene and pancreatic cancer risk M Giaccherini, R Farinella, M Gentiluomo, B Mohelnikova‐Duchonova, ... International Journal of Cancer 153 (2), 373-379, 2023 | 20 | 2023 |
Associations of urinary 8‐iso‐prostaglandin F2α levels with all‐cause dementia, Alzheimer's disease, and vascular dementia incidence: results from a prospective … K Trares, X Gào, L Perna, D Rujescu, H Stocker, T Möllers, K Beyreuther, ... Alzheimer's & Dementia 16 (5), 804-813, 2020 | 20 | 2020 |
Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus A Tin, P Schlosser, PR Matias-Garcia, CHL Thio, R Joehanes, H Liu, Z Yu, ... Nature communications 12 (1), 7173, 2021 | 19 | 2021 |